英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

请选择你想看的字典辞典：

单词	字典	翻译
795803	查看　795803　在百度字典中的解释	百度英翻中〔查看〕
795803	查看　795803　在Google字典中的解释	Google英翻中〔查看〕
795803	查看　795803　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://th.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://th.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Evergreen Therapeutics
Evergreen Therapeutics is an innovative biotechnology company, leveraging AI clinical expertise to redefine drug development
Uncategorized Archives - Evergreen Therapeutics - egmedai. com
Evergreen Therapeutics Announces Positive Results for EG-501 in Phase II Interim Analysis Evergreen Therapeutics recently announced that its AI‑enabled candidate EG‑501 has reached a major milestone The ongoing Phase II trial has completed enrollment of half its target participants, and an interim analysis of the data has returned positive outcomes
Privacy Policy - Evergreen Therapeutics - egmedai. com
Privacy Policy Welcome to Evergreen Therapeutics Evergreen Therapeutics, Inc (“Evergreen Therapeutics,” “we,” “us,” or “our”) cares about your
News - Evergreen Therapeutics
BioTech Breakthrough, a leading independent market intelligence organization evaluating top-tier innovations in the global life sciences and biotechnology sector, has announced the winners of its fifth annual BioTech Breakthrough Awards—with Evergreen Therapeutics receiving the Drug Development Innovation Award for the transformative role of its proprietary AI platform in accelerating
Open Roles - Evergreen Therapeutics - egmedai. com
Open Roles Working at Evergreen At Evergreen, people who power our work are our greatest asset We bring together curious minds, driven […]
Evergreen Therapeutics - egmedai. com
The post Evergreen Therapeutics and Vanderbilt University Medical Center Announce Positive Phase 2 Results for EG-501 in Lupus-Related Cognitive Impairmentappeared first on Evergreen Therapeutics
Scientific Approach - Evergreen Therapeutics - egmedai. com
Evergreen Therapeutics leverages AI technology to integrate multi-omics, clinical, and real-world data, thereby enhancing the quality of scientific design from the inception of drug development
Industry Radar - Evergreen Therapeutics - egmedai. com
Tracks the latest guidance and policy announcements from major international regulatory bodies
Pipeline - Evergreen Therapeutics
Evergreen Therapeutics is committed to advancing novel drug candidates addressing critical clinical gaps Our pipeline targets indications including Cognitive Impairment in NPSLE, Dry Age-Related Macular Degeneration (Dry-AMD), Preeclampsia, and other conditions with persistent unmet patient needs
Uncategorized Archives - Evergreen Therapeutics - egmedai. com
The post Evergreen Therapeutics Announces Full Enrollment in Phase II Trial of EG-501appeared first on Evergreen Therapeutics

中文字典-英文字典 2005-2009